HEPA - Hepion announces exercise of warrants for about $2M gross proceeds February, 16 2024 08:35 AM Hepion Pharmaceuticals Inc. 2024-02-16 08:35:34 ET More on ContraVir Hepion Pharma announces restructuring plan, sees $400–800 thousand charge for 4Q Seeking Alpha’s Quant Rating on ContraVir Historical earnings data for ContraVir Financial information for ContraVir For further details see: Hepion announces exercise of warrants for about $2M gross proceeds